The SA Journal Diabetes & Vascular Disease Volume 19 No 1 (July 2022)

NEW INTRODUCING OUR AMLODIPINE / VALSARTAN *FDC RANGE AMLODIPINE / VALSARTAN *FDC : • E ectively lowers BP2 • Gets up to 8/10 patients to goal 2 • Works synergistically to reduce oedema3 DILIGENT WORKERS | | | For further product information contact PHARMA DYNAMICS Email info@pharmadynamics.co.za CUSTOMER CARE LINE +27 21 707 7000 www.pharmadynamics.co.za CALSAR 5/80 mg, 5/160 mg, 10/160 mg. Each tablet contains amlodipine/valsartan 5/80 mg, 5/160 mg, 10/160 mg respectively. S3 A51/7.1.3/1106, 1107, 1108. For full prescribing information, refer to the professional information approved by SAHPRA, March 2021. 1) Data on file. 2) Karpov Y, et. al. Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertension. Advanced Therapeutics 2012;29(2):134-147. 3) Fogari R, et. al. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. Journal of Human Hypertension 2007;21:220-224. 4) Database of Medicine Prices (1 April 2022). Department of Health website. http://www.mpr.gov.za. *FDC - Fixed-dose combination. CRB927/05/2022. 5/80 5/160 10/160 mg mg mg                   FORMULARY LISTINGS1 DISCOVERY HEALTH Exec/Comp Core/Saver/Priority MPL MMAP MPR MMI UP TO 52 % LESS VS THE ORIGINATOR4 PACKED IN 30 TABLETS OFFERS A UNIQUE 5/80 mg DOSAGE

RkJQdWJsaXNoZXIy NDIzNzc=